Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

226.78 -3.33 (-1.45%)

Streaming Delayed Price Updated: 3:26 PM EDT, Mar 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,831,489
Open	229.97
Bid (Size)	226.71 (300)
Ask (Size)	226.84 (100)
Prev. Close	230.11
Today's Range	223.23 - 230.68
52wk Range	164.39 - 244.81
Shares Outstanding	N/A
Dividend Yield	3.05%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Quiet Outperformance From an Overlooked Dividend ETF ↗

Today 8:10 EDT

Via MarketBeat

1 Momentum Stock to Consider Right Now and 2 We Ignore

Today 0:39 EDT

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...

Via StockStory

Performance

YTD	-1.1%	-1.1%
1 Month	+1.5%	+1.5%
3 Month	+1.6%	+1.6%
6 Month	+8.1%	+8.1%
1 Year	+4.7%	+4.7%

More News

ABBVIE INC (NYSE:ABBV) Shows Strong Technical Setup for Potential Breakout ↗

March 06, 2026

Via Chartmill

These 3 Cash Flow Machines Provide Stability in Uncertain Markets ↗

March 06, 2026

Via MarketBeat

AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?

March 05, 2026

Via StockStory

AbbVie: The Only Big Pharma Stock I'd Consider a Buy‑and‑Never‑Sell ↗

March 04, 2026

Via The Motley Fool

Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive

March 03, 2026

Via Finterra

Why AbbVie Stock May Be the Ultimate Option for Dividend Investors ↗

March 02, 2026

Via The Motley Fool

Where Will AbbVie Be in 5 Years? ↗

February 26, 2026

Via The Motley Fool

Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics

February 25, 2026

Via MarketMinute

Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗

February 25, 2026

Via Stocktwits

This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income ↗

February 24, 2026

Via The Motley Fool

Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad

February 23, 2026

Via Finterra

1 Cash-Producing Stock to Target This Week and 2 We Ignore

February 22, 2026

Via StockStory

3 Stocks to Buy and Hold for 2026 and Beyond ↗

February 19, 2026

Via The Motley Fool

2 Dividend Stocks to Hold for the Next 5 Years ↗

February 19, 2026

Via The Motley Fool

What's going on in today's session: S&P500 movers ↗

February 18, 2026

Via Chartmill

6 Forever Dividend Stocks ↗

February 18, 2026

Via The Motley Fool

1 Mega-Cap Stock on Our Watchlist and 2 We Avoid

February 17, 2026

Via StockStory

8 Cheap Stocks to Buy in 2026 ↗

February 16, 2026

Via The Motley Fool

1 No-Brainer Dividend Stock to Buy on the Dip ↗

February 15, 2026

Via The Motley Fool

5 Best Stocks to Buy in February ↗

February 15, 2026

Via The Motley Fool

3 Dividend Stocks to Hold for the Next 20 Years ↗

February 15, 2026

Via The Motley Fool

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

February 14, 2026

Via The Motley Fool

Got $500? 2 Pharma Stocks to Buy and Hold Forever. ↗

February 14, 2026

Via The Motley Fool

Frequently Asked Questions

Is AbbVie publicly traded?

Yes, AbbVie is publicly traded.

What exchange does AbbVie trade on?

AbbVie trades on the New York Stock Exchange

What is the ticker symbol for AbbVie?

The ticker symbol for AbbVie is ABBV on the New York Stock Exchange

What is the current price of AbbVie?

The current price of AbbVie is 226.78

When was AbbVie last traded?

The last trade of AbbVie was at 03/09/26 03:26 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.